Tailored Rehabilitation Program for COPD Patients
Pulmonary Rehabilitation
Chronic Disease+5
+ Lung Diseases
+ Lung Diseases, Obstructive
Treatment Study
Summary
Study start date: April 30, 2026
Actual date on which the first participant was enrolled.This clinical study is focused on helping people with Chronic Obstructive Pulmonary Disease (COPD), a serious lung condition that makes it hard to breathe and affects day-to-day life. The study aims to test a special rehabilitation program that combines treatment at the hospital with exercises and activities that can be done at home. This program lasts for three months and includes education on managing COPD, dietary advice, exercise training for the arms and legs, and help to stop smoking. By doing this, the study hopes to improve how well patients can exercise, reduce their breathing difficulties, and overall enhance their quality of life. Participants in the study will engage in various activities both at the hospital and at home. In the hospital, they will receive training and support from healthcare professionals. At home, they will continue with daily walking and strength exercises, and make changes to their lifestyle as advised. The study measures progress by looking at how far participants can walk in six minutes, checking their breathing difficulties, and using questionnaires to assess their respiratory health and overall quality of life. Tests like spirometry and blood gas analysis are also conducted before and after the program to see how much improvement there is. These assessments help determine if the combination of hospital and home-based care is beneficial for people with COPD.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.70 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * Stable COPD patients diagnosed based on spirometry (post-bronchodilator FEV1/FVC \<70%) Age \> 40 years Moderate to severe COPD stage Able and willing to participate in rehabilitation program Exclusion Criteria: * Age \< 40 years Current acute COPD exacerbation at enrollment Significant comorbid conditions limiting participation (e.g., uncontrolled diabetes mellitus, uncontrolled hypertension, left-sided heart failure, renal failure, liver cell failure) Neuromuscular diseases, severe cognitive impairment, or psychiatric disturbance Pregnant patients Unwilling to participate in the rehabilitation program
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives